Form 8-K Avalanche Biotechnologie For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Avalanche Biotechnologies (AAVL) Tops Q2 EPS by 1c
August 13, 2015 4:11 PM EDTAvalanche Biotechnologies (NASDAQ: AAVL) reported Q2 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $203 thousand versus the consensus estimate of $760 thousand.
For earnings history and earnings-related data on Avalanche Biotechnologies (AAVL) click here.
... More


